8:11AM Lannett receives FDA approval for Phentermine resin extended-release capsules, 15 mg and 30 mg (LCI) 4.67 : Co announced the FDA approved its Abbreviated New Drug Application for Phentermine Resin Extended-Release Capsules, 15 mg and 30 mg, representing the fourth product approval the co has received in the last five weeks. Phentermine Resin Extended-Release Capsules, 15 mg and 30 mg, are therapeutically equivalent to the reference listed drug, Ionamin Capsules, 15 mg and 30 mg, of UCB, Inc. This product will be sold through bariatric clinics.
surf's up......crikey